Stock Detail
$ABBV
Healthcare · 8 tracked mentions in the last 90 days across 5 creators.
Valuation and creator stance reflect the last 90 days. The mention feed below shows the latest tracked mentions across all history.
ABBV leans undervalued across 3 creators and 4 classified valuation claims, with 3 direct claims carrying most of the signal.
Creator Evidence
Why creators say this
Explicit claim • strong conviction • basis: fair value gap
I have a blended intrinsic value on ABBV of $275.90. They're currently trading below that value.
Explicit claim • strong conviction • basis: multiple relative
and drug maker AbbVie ticker ABBV which trades for 18 times earnings even after it's 35% run.
Explicit claim • strong conviction • basis: fair value gap
And the next stock is where the ranking starts to become much more interesting because this is the first one where my valuation model shows a margin of safety above 20% and that is ABV.
Explicit claim • strong conviction • basis: price target upside
I really think this stock in the long run will give you 7 to 8% total return of your money back a year. If you look right now in the middle of my screen, no matter what you're getting 3.4% of your money back just in a qualified dividend every year, but I'm going to show you why I believe AbbVie will give you 3 to 4% stock price appreciation on top of this 3 and 1/2% dividend every single year on average.
Mention History
Latest mentions across all history
Feed